Zprávy
Martin Ondra successfully defended his dissertation on Cell Models to Study Pathophysiology of Cystic Fibrosis
May 6, 2024 / IMTM Seminary room
EATRIS-CONNECT: The new project has launched!
This 3-year project brings together 21 organisations to accelerate translational medicine through digital transformation.
IMTM Junior Researchers Actively Participated at AFO59
Martin Ondra and Jarka Stankova, junior researchers from IMTM, actively participated in the events of the 59th ACADEMIA FILM OLOMOUC FEST.IVAL
Interview with Vladimíra Koudeláková, the head of the virology and molecular carcinogenesis research group at IMTM [CZ]
The new research group of the Olomouc node of NICR was launched in 2023 at IMTM. Step into their multidisciplinary lab and learn about their astonishing work in this interview.
IMTM YouTube kanál
Featured publications
High speed of fork progression induces DNA replication stress and genomic instability.
Nature.
2018,
559(7713),
279-284,
ISSN: 0028-0836,
IF: 41.577,
PMID: 29950726.
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4.
Nature.
2017,
552(7684),
194-199,
ISSN: 0028-0836,
IF: 40.137,
PMID: 29211715.
Bridging the translational innovation gap through good biomarker practice.
Nature Reviews. Drug Discovery.
2017,
16(9),
587-588,
ISSN: 1474-1776,
IF: 57.000,
PMID: 28450744.
Putting translational science on to a global stage.
Nature Reviews Drug Discovery.
2016,
15,
217-219,
ISSN: 1474-1776,
IF: 57.000,
PMID: 27032820.
A Synergistic Interaction between Chk1-and MK2 Inhibitors in KRAS-Mutant Cancer.
Cell.
2015,
162(1),
146-159,
ISSN: 0092-8674,
IF: 28.710,
PMID: 26140595.
REV7 counteracts DNA double-strand break resection and affects PARP inhibition.
Nature.
2015,
521(7553),
541-544,
ISSN: 0028-0836,
IF: 38.138,
PMID: 25799992.